Sponsored by:

Nuclear Medicine: Page 361

European nuclear medicine market shows limited growth
By AuntMinnie.com staff writers
An estimated 5.4 million diagnostic nuclear medicine patient studies were performed in Western Europe in 2005, a negligible increase from 2004, according to a new study published by healthcare consultants Medical Options of London.
April 24, 2006
Eastern Isotopes changes identity
By AuntMinnie.com staff writers
Ion Beam Applications (IBA) has changed the name of its Eastern Isotopes U.S. subsidiary to IBA Molecular.
April 20, 2006
C-11 topotecan PET shows promise for predicting therapeutic response
By Jonathan S. Batchelor
PET and PET/CT have demonstrated superiority in staging most cancers, depending on the radiopharmaceutical tracer used in the imaging study. The technology has also proved its strength in myocardial perfusion exams. The next frontier for the modality may be determining the efficacy of drug therapies for oncology patients, according to research presented at the 2006 Academy of Molecular Imaging (AMI) meeting in Orlando, FL.
April 20, 2006
IsoRay names Hunt as controller
Medical isotope developer IsoRay Medical has appointed Jonathan Hunt as its corporate controller.
April 18, 2006
International Isotopes shows year-end sales uptick
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes of Idaho Falls, ID, reported a 5% increase in total revenues for its 2005 fiscal year to $2.9 million, compared with $2.8 million for fiscal 2004.
April 17, 2006
Boston Life Sciences issues 'going concern' warning
By AuntMinnie.com staff writers
Pharmaceutical firm Boston Life Sciences (BLSI) of Boston has issued a warning in its annual report regarding the company's ability to continue as a going concern.
April 9, 2006
Massachusetts bill takes aim at physician self-referral
By Kate Madden Yee
Radiology advocates in the U.S. have become increasingly frustrated at their inability to get the federal government to restrict physician self-referral. Now there are signs that such efforts may bear more fruit at the state level, with the state of Massachusetts mulling a ban on the practice for MRI, PET, and linear accelerator services.
April 3, 2006
Limiting scan range cuts dose, boosts throughput in melanoma PET/CT
By Jonathan S. Batchelor
ORLANDO, FL - The current PET/CT protocol of scanning all melanoma patients from the crown of the head to the soles of the feet, including dedicated brain studies, may be providing little clinical value and putting patients on the gantry longer than needed, according to a study from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
March 29, 2006
DraxImage shelves Fibrimage, unveils new generics initiative
By AuntMinnie.com staff writers
Radiopharmaceutical firm DraxImage has decided to realign its research and development activities, a process that will include a new effort to develop generic radiopharmaceuticals.
March 27, 2006
PET registry primed for takeoff
By Jonathan S. Batchelor
ORLANDO, FL - The National Oncologic PET Registry (NOPR), which debuted last year at the Academy of Molecular Imaging (AMI) annual meeting, holds the promise of broadening the scope of the types of oncologic PET scans that can be conducted on Medicare patients. Dr. Barry Siegel from the Mallinckrodt Institute of Radiology in St. Louis presented an update on the status of the project at the 2006 AMI meeting on Sunday.
March 26, 2006
Siemens to unveil Inveon, 40-slice PET/CT, at AMI
By AuntMinnie.com staff writers
Siemens Medical Solutions is introducing a new preclinical imaging product, Inveon, at next week's Academy of Molecular Imaging (AMI) meeting in Orlando, FL.
March 23, 2006
Positron gets Health Canada nod
By AuntMinnie.com staff writers
PET vendor Positron said that Health Canada had granted approval to use the vendor's mPower PET scanner in oncology and cardiology clinical trials in Canada.
March 21, 2006
Previous Page
Page 361 of 440
Next Page